Japan integrates ICH guidelines into drug quality audits by aligning its regulatory framework with international standards, ensuring consistency in quality, safety, and efficacy. The Pharmaceuticals and Medical Devices Agency (PMDA) collaborates with global counterparts, adopting ICH Q-series guidelines to harmonize processes, enhance inspections, and facilitate mutual recognition of audit outcomes.
